506-48-9
Chemical Structure
Octacosanoic acid
Synonym(s): Montanic acid
- CAS No.: 506-48-9
- Formula:C28H56O2
- Molecular Weight:424.74
IUPAC Name: octacosanoic acid
InChIKey: UTOPWMOLSKOLTQ-UHFFFAOYSA-N
SMILES: CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O
Biological Activity: Octacosanoic acid (Montanic acid) is a long-chain saturated fatty acid and a major component of sugarcane wax mixture and D-003. Octacosanoic acid can be formed in the liver from Octacosanol (HY-N6811) and inhibits nitric oxide (NO) production in LPS-activated macrophages and LPS-induced splenic lymphocyte proliferation. Octacosanoic acid can be used in anti-inflammatory and lipid metabolism-related research[1][2][3][4][5][6][7].
| Cat. No. | 상품명 | Purity | 제품 설명 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Octacosanoic acid | 98.0% | Octacosanoic acid (Montanic acid) is a long-chain saturated fatty acid and a major component of sugarcane wax mixture and D-003. Octacosanoic acid can be formed in the liver from Octacosanol (HY-N6811) and inhibits nitric oxide (NO) production in LPS-activated macrophages and LPS-induced splenic lymphocyte proliferation. Octacosanoic acid can be used in anti-inflammatory and lipid metabolism-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Octacosanoic acid (Standard) | ≥98% | Octacosanoic acid (Montanic acid) (Standard) is the analytical standard of Octacosanoic acid (Montanic acid) (HY-N8425). This product is intended for research and analytical applications. Octacosanoic acid (Montanic acid) is a long-chain saturated fatty acid and a major component of sugarcane wax mixture and D-003. Octacosanoic acid can be formed in the liver from Octacosanol (HY-N6811) and inhibits nitric oxide (NO) production in LPS-activated macrophages and LPS-induced splenic lymphocyte proliferation. Octacosanoic acid can be used in anti-inflammatory and lipid metabolism-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Mendoza MS, et al. Comparison of the effects of D-003 and policosanol on lipid profile and endothelial cells in normocholesterolemic rabbits. Current therapeutic research. 2001 Mar 1;62(3):209-20.
- [2]. Hil AL, et al. Chemical composition and antimicrobial activity of the hexanic extract from the leaves and stems of Croton micradenus (Euphorbiaceae). Acta Botánica Cubana. 2023 Jul 10;222:cu-id.
- [3]. Noa M, et al. D-003 does not possess oestrogenic potential in-vivo: findings of the uterotrophic assay. The Journal of pharmacy and pharmacology. 2007 Oct;59(10):1433-7.
- [4]. Molina V, et al. Synergistic effect of D-003 and aspirin on experimental thrombosis models. Prostaglandins, leukotrienes, and essential fatty acids. 2003 May;68(5):305-10.
- [5]. Ety Sari Handayani, et al. Black sugarcane decoction reduces rat brain ischemia. Univ Med. 2016;35(1):40-45.
- [6]. Benramdane E, et al. Lipophilic Compounds and Antibacterial Activity of Opuntia ficus-indica Root Extracts from Algeria. Int J Mol Sci. 2022 Sep 22;23(19):11161.
- [7]. Yang NianYun YN, et al. Immunological activities of components from leaves of Liriodendron chinensis. Chinese Herbal Medicines, Volume 7, Issue 3, 2015, Pages 279-282, ISSN 1674-6384,
